Rae Hyndman was diagnosed with advanced ovarian cancer in November 2023, after noticing bloating in her stomach.

A woman who struggled to recover from a bout of food poisoning after her Christmas work do went on to be diagnosed with a ...

Lindsay Barad felt like she was in the best shape of her life. But everything changed after a doctor's appointment revealed ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves - insights that could help researchers develop more effective treatment strategies.

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights that could help researchers develop more effective treatment strategies.

CORT's relacorilant combo targets platinum-resistant ovarian cancer in new NDA, backed by positive ROSELLA study data.

DNA G-quadruplexes appear to substantially help ovarian cancer cells activate genes that counteract chemotherapy, effectively shielding the tumor from treatment.

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in patients with platinum-sensitive ovarian cancer.

After announcing her breast cancer diagnosis earlier this month, Jessie J underwent surgery and shared photos with son Sky Safir and boyfriend Channan Safir Colman following the procedure.

She received further surgery and chemotherapy and is now on olaparib, a drug developed by Cancer Research UK-funded scientists in Cambridge to prevent breast and ovarian cancers from coming back.

Novel drug combinations that improve survival outcomes, questions about treatment sequence, and encouraging results in chemo-resistant disease are highlights in ovarian cancer from ASCO 2025.